Abstract
A simple and rapid HPLC method that includes ultrafiltration to remove plasma and tissue interference component was developed to determine 5-Fluorouracil (5-FU) concentration in mouse plasma and tissues (heart, liver, spleen, lung, and kidney). Following ultrafiltration, standards, quality controls, and plasma samples were separated by reversed-phase HPLC on an ODS analytical column and quantified using UV detection at 265 nm. The mobile phase was 5 mM phosphate buffer (pH 5)-methanol (95:5, v/v), with a flow-rate of 0.6 mL/min. The calibration curves for 5-FU in mouse plasma and tissue samples were all linear (r2 > 0.997) over the drug concentration range of 40 to 25000 ng/mL. For all plasma and tissue samples, both the intra- and inter-day precisions were less than 5% expressed in RSD, and the accuracy was between 96 and 104%. The limit of detection was 20 ng/mL. The overall recoveries were >73%. The method was illustrated with a preliminary in vivo analysis on 3 mice treated with intravenous injection of 5-FU, and most of the drug was found deposited in mouse liver 1 hour after the administration.
ACKNOWLEDGMENTS
This work was supported by both Shandong Provincial Natural Science Foundation (grant number ZR2010HL067) and JMC Science and Research Project Startup Fund for PhD Faculty.
Notes
a y = Ax + B with a weighting of 1/y; y is the peak area ratio; x, the concentration of 5-FU; A, the slope; B, the intercept. The value of each parameter is the mean value, and the value in each pair of parentheses is RSD (%).
a The value of each parameter is the mean value, and the value in each pair of parentheses is RSD (%).
a The stability test results of 5-FU in the plasma and tissue ultrafiltrates at room temperature and at −20°C was assessed by spiking mouse plasma and tissues with 5-FU at 40, 1000, and 25000 ng/mL.
b The value of each parameter is the mean value, and the value in each pair of parentheses is RSD (%).